期刊论文详细信息
Influenza and Other Respiratory Viruses
A prospective study of chemotherapy immunologic effects and predictors of humoral influenza vaccine responses in a pediatric oncology cohort
Leslie S. Kersun5  Anne Reilly5  Susan E. Coffin2  Jean Boyer3  Eline T. Luning Prak6  Kenyetta McDonald4  Xiaoling Hou1  Abbas F. Jawad1 
[1] Department of Pediatrics, The Children’s Hospital of Philadelphia, Philadelphia, PA, USA.;Division of Infectious Diseases, Department of Pediatrics, The Children’s Hospital of Philadelphia, Philadelphia, PA, USA.;Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.;Division of Allergy Immunology, Department of Pediatrics, The Children’s Hospital of Philadelphia, Philadelphia, PA, USA.;Division of Oncology, Department of Pediatrics, The Children’s Hospital of Philadelphia, Philadelphia, PA, USA.;Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
关键词: ALL;    antibody;    B cell;    ELISPOT;    influenza;    vaccine;   
DOI  :  10.1111/irv.12058
来源: Wiley
PDF
【 摘 要 】

Abstract

Please cite this paper as: Kersun et al. (2013) A prospective study of chemotherapy immunologic effects and predictors of humoral influenza vaccine responses in a pediatric oncology cohort. Influenza and Other Respiratory Viruses 7(6), 1158–1167.

Background:  Pediatric oncology patients represent a cohort of individuals uniquely at risk of complications from influenza, yet less likely to respond to the vaccine. It is not yet clear how to best protect this vulnerable population.

Methods:  We performed a prospective analysis of 177 pediatric oncology patients to define the predictors of influenza vaccine responses. Each variable was examined over three time points and a repeated measure analysis was performed.

Results:  Patients with ALL vaccinated during induction phase had superior influenza vaccine responses than those subjects vaccinated during post-induction or maintenance phases (P = 0·0237). Higher aggregate HAI titer responses were associated with a higher baseline B-cell count (P = 0·0240), and higher CD4 and CD8 influenza-specific T-cell responses, suggesting prior antigen exposure is a significant contributor. The solid tumor cohort had equivalent responses during all time frames of chemotherapy.

Discussion:  The optimal protection from influenza of pediatric patients on chemotherapy should include vaccination, but it is clear that not all patients produce high titers of antibodies after vaccination. This study identified biomarkers that could be used to individualize vaccine approaches. Immunologic predictors might have a role in targeting resources, as B-cell counts predicted of vaccine responses among the patients with ALL.

【 授权许可】

Unknown   
© 2012 John Wiley & Sons Ltd

【 预 览 】
附件列表
Files Size Format View
RO202107150012192ZK.pdf 368KB PDF download
  文献评价指标  
  下载次数:28次 浏览次数:4次